Share tips of the week
MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
Three to buy
Aviva
(Shares) Aviva has reported “robust” half-year results and reinstated its dividend. Yet shares in the insurer trade on just 6.5 times forward earnings, one of the lowest ratings in the FTSE 100. That looks unjustified. New boss Amanda Blanc is refocusing the business on core markets in the UK, Ireland and Canada and has already sold the “prized” Singapore operation for £1.6bn. The cash will help Aviva to reduce leverage and the strategy should ultimately pave the way for higher investor returns. 301p
Domino’s Pizza
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Sunday Telegraph) Recent coverage of this pizza chain has been dominated by spats between management and franchisees about the pace of new store openings. However, lockdown gave both sides a slice of the action as housebound consumers turned to food delivery. That generated a 3.7% jump in first-half underlying sales and could help ease the way to better relations in the future. The shares are worth a bite. 341.75p
Ocado
(The Mail on Sunday) Ocado’s shares are expensive and the company is loss-making. But lockdown seems to have shifted shopping habits, with consumers still ordering online at an “unprecedented rate”. A new partnership with Marks & Spencer is going well, coinciding with a 52% leap in third quarter revenue. It is also partnering with big supermarkets in the US and France for their online operations. With a grim “stay-at-home winter” looming, the attractions of the virtual checkout will grow. 2,817p
Three to sell
Premier Oil & Tullow Oil
(Interactive Investor) Weak oil prices have turned these two independent oil producers into “proverbial ‘zombies’” – companies that are using debt to stay afloat while praying that oil prices improve. That hasn’t stopped speculative fever – both saw their share prices more than triple between March and mid-June. Yet renewed doubts about global demand for “black gold” this autumn have seen those gains unwind while interim results have been little short of “carnage”. Such volatile, “snakes and ladders” shares are not for long-term investors, so steer clear. 17.5p and 15p
The Hut Group
(The Evening Standard) Investors have piled into this newly floated e-commerce specialist, which sells everything from mascara to sports nutrition products. The e-commerce outsourcing arm Ingenuity is an especially compelling growth play. Yet this float has “got more red flags than Tiananmen Square”. All the big banks are involved in the IPO so there are few sceptics to be found, while early backer KKR is selling all of its stake, which is hardly a ringing endorsement. The post-float corporate governance arrangements are also “all over the place”. Wait six months to see how things “settle” before putting any of your own money on the line. 610p
Greencore
(The Times) This Irish convenience-food group was in a sweet spot. Then the pandemic struck, keeping people stuck at home and making their own sandwiches. The group’s food-to-go revenue halved between late March and June and its “convalescence” is proving slow going. Food-processing plants are also vulnerable to virus outbreaks. Avoid. 111.25p
...and the rest
The Daily Telegraph
Wind power requires big, complex machinery, which keeps new entrants out of the market. That has ensured fast-rising profits for Danish renewables pioneer Vestas (DKr948.8). Motoring accident credit and legal specialist Anexo could prove a bargain at the current valuation (127.5p).
Investors Chronicle
Shares in Adobe have been swept up by this year’s US tech surge but even on 48 times forecast earnings they are still a buy: this business combines the reliable cash-generation of an established name with the growth prospects of a digital play ($471). Hurricanes and wildfires have left many Americans in the dark this year. That should bring rising demand for back-up power specialist Generac ($184).
The Mail on Sunday
Aim-listed online mattress seller Eve Sleep has been a “nightmare” investment in recent years but a 25% sales jump in the second quarter suggests that it is well-placed to capitalise if a “miserable winter” keeps families out of physical stores (4.85p).
Shares
Shares in audio technology play Focusrite are up by almost one-fifth since July and should continue to rise on the back of structural tailwinds (819p). Smart Metering Systems has been resilient this year. Hold for the generous dividend policy (660p).
The Times
Premium drinks maker Fever-Tree is going from strength to strength and has room to expand in the United States (2,183p). Loungers, which operates café bar chains, is well-placed to flourish when life returns to normal (170p).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
The star small and mid-cap stocks income investors have overlooked
Opinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
By Thomas Moore
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Chemring Group: an explosive investment opportunity in defence
European states are raising their military spending, and Chemring Group looks well placed to profit
By Rupert Hargreaves
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves